The United States is in the midst of an opiate epidemic, with abuse of prescription and illegal opioids increasing steadily over the past decade. While it is clear that there is a genetic component to opioid addiction, there is a significant portion of heritability that cannot be explained by genetics alone. The current study was designed to test the hypothesis that maternal exposure to opioids prior to pregnancy alters abuse liability in subsequent generations. Female adolescent Sprague Dawley rats were administered morphine at increasing doses (5e25 mg/kg, s.c.) or saline for 10 days (P30-39). During adulthood, animals were bred with drug-naïve colony males. Male and female adult offspring (F1 animals) were tested for morphine self-administration acquisition, progressive ratio, extinction, and reinstatement at three doses of morphine (0.25, 0.75, 1.25 mg/kg/infusion). Grandoffspring (F2 animals, from the maternal line) were also examined. Additionally, gene expression changes within the nucleus accumbens were examined with RNA deep sequencing (PacBio) and qPCR. There were dose-and sex-dependent effects on all phases of the self-administration paradigm that indicate decreased morphine reinforcement and attenuated relapse-like behavior. Additionally, genes related to synaptic plasticity, as well as myelin basic protein (MBP), were dysregulated. Some, but not all, effects persisted into the subsequent (F2) generation. The results demonstrate that even limited opioid exposure during adolescence can have lasting effects across multiple generations, which has implications for mechanisms of the transmission of drug abuse liability in humans.
Introduction
The cost of opiate addiction is exceedingly high to individuals and society (Li and Burmeister, 2009) ; however, the effect of widespread exposure to opiates on future generations is unknown. There is a growing body of evidence demonstrating that experiences of one generation can have lasting effects on subsequent generations. For example, inter-generational effects have been documented in animal models following variations in stress, diet, as well as toxin and drug exposures (Skinner, 2015) . Following exposure to drugs of abuse animal studies have found both increases and decreases in offspring propensity towards addictionlike behaviors (Szutorisz et al., 2014; Vassoler et al., 2013 Vassoler et al., , 2016 that indicate alterations within the reward pathway that may increase vulnerability in certain populations. There remains a paucity of studies examining transgenerational effects following exposure to drugs of abuse.
Transgenerational epigenetics refers to the transmission of a phenotype across multiple generations of a species in the absence of changes in the DNA sequence (Bohacek et al., 2013; Franklin and Mansuy, 2010; Gapp et al., 2014; Skinner, 2015; Yohn et al., 2015) . The term is limited to effects that extend to a generation that was not exposed to the initial environmental manipulation. Thus, in the absence of in utero exposure, grandoffspring of female animals that show an effect are demonstrating transgenerational epigenetic inheritance. There is mounting evidence that supports the hypothesis that preconception drug use has effects on multiple generations (Vassoler et al., 2014a; Yohn et al., 2015) . However, this distinction should not downplay the significance of preconception drug exposure on the F1 generation, as these also have significant implications for public health.
In the current set of studies we tested the hypothesis that female adolescent morphine exposure, terminating several weeks prior to pregnancy, would increase opiate abuse liability in offspring and grandoffspring. Further, based on other studies examining sex differences in opiate self-administration, we hypothesized that females will take more morphine than males (Cicero et al., 2003) . Finally, we hypothesized that the effect would be diminished in the F2 generation as there was no direct exposure in F2 animals . Voluntary responding of male and female F1 and F2 animals was measured during morphine self-administration acquisition, PR, extinction and drug-primed reinstatement, as these model distinct phases of substance use (i.e. addiction/reinforcement, withdrawal/rehabilitation, and relapse). We then used deep sequencing to identify pathways of gene expression changes in the nucleus accumbens in F1 animals. The nucleus accumbens was chosen based on its role in addiction and on our previous work demonstrating transgenerational effects on receptor expression within the accumbens using this model . Based on sequencing data, high level targets related to neuroplasticity were identified. The genes were examined using qPCR in the nucleus accumbens of both F1 and F2 animals of both sexes.
The data revealed significant decreases in the acquisition, extinction, and reinstatement of morphine self-administration that were sex-and dose-dependent. A number of effects were observed in both F1 and F2 animals demonstrating transgenerational epigenetic inheritance as a function of maternal drug history. Taken together, we show that female adolescent morphine exposure, in the absence of any direct fetal exposure, induces sex-specific transgenerational epigenetic effects that span at least two generations. These findings suggest the inheritance of homotypic drug resistant phenotypes following parental exposure to drugs of abuse.
Materials and methods

Animals and housing
For all experiments, post-natal day 23 (PND23) female SpragueDawley rats [Crl:CD(SD)BR] were purchased from Charles River Breeding Laboratories. All animals were housed in standard acrylic laboratory cages at Cummings School for Veterinary Medicine at Tufts University. Animals were maintained on a 12-hour light/dark cycle with lights on at 7:00 a.m. and all procedures were performed during the light phase. Food and water was available ad libitum, unless otherwise stated. All procedures were approved by the Institutional Animal Care and Use Committee of Tufts University, and were carried out in accordance with the National Research Council (NRC) Guide for the Care and Use of Laboratory Animals.
Generation of F0, F1, and F2 animals
All animals were housed 3e4 per cage. The adolescent exposure is described in Vassoler et al., 2015. Briefly, beginning at PND30 females (n ¼ 36) were injected (s.c.) once daily with morphine sulfate (MS) for a total of 10 days using an increasing dosing regimen with doses increased every other day (5, 5, 10, 10, 15, 15, 20, 20, 25, 25 mg/kg) . Age-matched control animals (n ¼ 36) received saline injections (s.c) with volumes adjusted to match those of drug-treated females. On PND 60e80 (3e6 weeks after their final injection), females were mated with drug-naïve colony males. Each male was placed with 4 age-matched females (2 morphine treated and 2 saline treated). Once an animal was visibly pregnant (approximately E16-E20) she was housed singly. On PND1 (day of birth ¼ PND0) all litters were culled to ten pups (5 male, 5 female) (Kosten et al., 2014) . The weight of the pups and the dam was recorded. All litters were weighed and weaned on PND21 and housed with same-sex littermates. No differences in bodyweights were observed at either time point (data not shown). To generate F2 animals (grandoffspring), naïve, adult, female F1 animals were mated with drug-naïve colony males in the same way as F0 animals (ie. 4 females per male, two MOR-F1 and two SAL-F1). Offspring were culled to ten pups (5 male, 5 female) on PND1. All litters were weighed and weaned on PND21 and housed with same sex littermates. It is important to note that F1 female animals used to generate F2 grandoffspring did not receive any drug or behavioral manipulations. Offspring of morphine-exposed females are designated Mor-F1. Offspring of saline controls are designated Sal-F1. Grandoffspring are designated Mor-F2 and Sal-F2, respectively. All testing was conducted once F1 and F2 animals were at least 60 days of age. In all of the reported findings only one offspring per litter was used in any individual treatment group. Table 1 Animals were anesthetized using a ketamine/xylazine cocktail (80 mg/kg and 8 mg/kg, respectively). The catheter (CamCaths, Cambridge, UK) was composed of silastic tubing that was fed into the right external jugular vein and routed to a mesh backmount platform secured subcutaneously between the shoulder blades. Catheters were flushed daily with an antibiotic (Cefazolin, 0.02 mg/ ml) dissolved in heparinized saline and sealed with plastic obturators when not in use.
Apparatus
Self-administration was conducted in operant chambers housed within sound-attenuating cubicles (MedAssociates, St. Albans, VT). Chambers were equipped with house lights, cue lights, and two retractable levers (one active; one inactive). Active lever pressing initiated the activation of the syringe pump (MedAssociates) to deliver a drug infusion (rate 60 ml in 5 s, 15 s post-infusion timeout).
Drug delivery and data collection were controlled by MedAssociates software (MedPCIV). Following catheterization surgery, animals were recovered for 1 week prior to initiation of selfadministration.
Acquisition/progressive ratio
Animals were allowed to self-administer morphine (0.25, 0.75, or 1.25 mg/kg/infusion; the dose was a between subjects variable, thus different animals were used for each dose) for 15 days on a fixed ratio 1 (FR1; one lever press ¼ one infusion) schedule of reinforcement. Each session was 2 h long. A cue light was illuminated over the active lever during the infusion for FR1 only, there were no cues associated with FR5, PR, extinction, or reinstatement. There was a 15 s time out following an infusion. Responding that is presented is from the active phase and does not include the time out period. Following 15 days of FR1, the animals were switched to a FR5 (five lever presses ¼ one infusion) schedule for 5 days. This allowed for a greater response output in the animals. After the fifth day on FR5 animals were tested on a progressive ratio schedule of reinforcement. Under a PR schedule the response requirement for each subsequent drug delivery was increased until the subject failed to meet a requirement. The response requirement for the ith reinforcement was given by R(i) ¼ [5e 0.2i -5] and the session expired when an animal took more than 60 min to receive an injection. The breakpoint was operationally defined as the number of responses prior to the termination of the session. The following day, the animals entered into the extinction phase.
Extinction and reinstatement
The FR5 schedule was utilized throughout extinction and reinstatement testing. Additionally, saline was available in the syringe pump during these phases. Extinction testing was conducted for 2 h/day for 10 days. All animals reached extinction criteria (<15% of last day of self-administration) by 10 days of extinction. The animals then underwent reinstatement. All animals were tested with saline first (i.p.). One extinction day was used between the saline and morphine reinstatement tests. On the morphine reinstatement day, morphine (1 mg/kg, i.p.) was administered immediately prior to the reinstatement session. Active and inactive lever presses as well as infusions were recorded during these sessions.
2.4. Sucrose pellet self-administration was performed similar to that of morphine self-administration Animals were mildly food restricted (~95% free feeding bodyweight) and allowed to self-administer sucrose pellets (Bioserve, Flemington, NJ) for 10 days on an FR1 schedule. They were then switched to an FR5 schedule for 5 days. All sessions were 1 h long. Following this acquisition phase, animals were tested on a PR schedule (see description above). They then underwent extinction for 10 days prior to reinstatement. On the reinstatement test day, animals were given non-contingent sucrose pellets, one pellet every two minutes for the first 10 min via remote administration. Responses were recorded.
Brain dissection and tissue preparation
Adult (PND60-72), naïve, F1 animals were utilized for deep sequencing, while both F1 and F2 naïve adults were used for followup qRT-PCR analysis. Animals were decapitated, and brains were rapidly removed, frozen in methylbutane, and stored at À80 C. To collect samples for analysis of gene expression, frozen brains were mounted on a cryostat and bilateral micropunches were taken from the NAc (2 mm; starting at: þ2.5 mm A/P, ±1.5 mm M/L, À7 mm D/ V, a region encompassing both core and shell) according to Paxinos and Watson (Paxinos and Watson, 1997 ).
Sequencing and analysis
Sequencing
For each group, accumbal tissue from 6 animals was pooled for sample preparation. Total RNA was extracted using the Qiagen midi RNeasy kit (Valencia, CA, USA). Ribosomal RNA was depleted using the Ribo-Zero kit according to manufacturer's protocols (epicenter). Double stranded cDNA was synthesized with the superscript dscDNA kit (ThermoFisher, Waltham, MA) . In between the first and second strand synthesis, the PreCR repair Mix was utilized to fill in nicks in the DNA (New England Biolabs, Ipswich, MA). The samples were then checked for integrity using the bioanalyzer (Agilinent Technologies, Santa Clara, CA). Samples were run through the Pacific Bio Sequencer at the University of Massachusetts School of Medicine Core Facility (Pacific Biosciences RSII Instrument; P4/C2 version run chemistry with 120-minute data collection times and smrtportal data analysis).
Analysis of sequencing
Pac-Bio reads were aligned to the Rat genome downloaded from UCSC ftp://hgdownload.cse.ucsc.edu/goldenPath/rn5/bigZips/rn5. fa.gz using two separate aligners (GMAP (Wu and Watanabe, 2005) and STAR (Dobin et al., 2013) ), in order to validate read mapping. Output SAM files were further processed with Samtools (Li et al., 2009 ) to filter reads that failed to map to the genome. Finally, reads were counted for each gene using featureCounts (Liao et al., 2014 ) in R (RCoreTeam, 2015 . Expression change estimates were generated with edgeR (Robinson et al., 2010) , and reads were prioritized based upon log-fold change in genes with greater expression levels than 10 log counts/million. Gene lists were then inputed into gene ontology program, GeneMANIA as well as into the gene list enrichment analysis tool, Enrichr Warde-Farley et al., 2010) .
Quantitative reverse transcriptase polymerase chain reaction (qrtPCR) and quantification
Tissue punches were homogenized in lysis buffer and total RNA extracted using the RNeasy kit from Qiagen (Valencia, CA, USA) according to the manufacturer's protocol. Complementary DNA (cDNA) was synthesized using the RETROscript kit from Applied Biosystems (Carlsbad, CA, USA). PCR was performed using an AB 7500 (Applied Biosystems) under standard amplification conditions: 2 min at 50 C, 10 min at 95 C, 40 cycles of 15 s at 95 C and 60 s at 60 C. All PCR primers were TaqMan ® Gene Expression Assays purchased from Applied Biosystems. The amplification efficiency of each of these assays has been validated by Applied Biosystems and averages 100% (±10). Assay ID numbers were as follows: S16:Rn01476520_g1, MBP:RN01399619_m1, Gria2:Rn00568514_m1, zwint:Rn00595851_m1, snap25:Rn00578534_m1, ApoE: Rn00593680_m1, TMSB4X: Rn00821311_g1.
Quantification of gene transcription
Final quantification of mRNA was obtained using the comparative cycle threshold (CT) method (User Bulletin #2, Applied Biosystems). All samples were run in duplicates and the average CT value was used. Data are reported as relative transcription or the Nfold difference relative to a calibrator cDNA. In brief, the housekeeping gene for the rat brain tissue, S16, was used as an internal control against which each target signal was normalized; this is referred to as the DCT. Validation studies confirmed that the raw CT values of S16 did not vary by treatment group, confirming S16 as an 
Statistical analyses
F1 acquisition and PR data were analyzed with two-way ANOVAs with maternal treatment and dose as factors. Extinction data were analyzed with repeated measures two-way ANOVA with day as the repeated measure and maternal treatment as the between subjects factor. All reinstatement data were analyzed with a two-way repeated measures ANOVA with maternal treatment as a between subjects factor and dose as a within subjects factor. F2 (except extinction and reinstatement), and qPCR data were analyzed using student's t-test. Sidak's multiple comparison post hocs were used when appropriate. Significance was defined as p < 0.05. In all experiments data for each sex was analyzed separately. This was determined a priori due to the complexity of the design and the questions being addressed.
Results
F1 morphine self-administration acquisition, progressive ratio, extinction, and reinstatement
Male and female F1 animals were trained to self-administer morphine at one of 3 doses (0.25, 0.75, or 1.25 mg/kg/infusion, separate animals for each dose) during adulthood. The paradigm included 4 phases: acquisition, PR, extinction, and reinstatement. Fig. 1 shows the acquisition and PR data. In males, there was a significant decrease in morphine intake by Mor-F1 males (Fig. 1A) as well as a decrease in breakpoint (Fig. 1B) at the highest dose compared with Sal-F1 males. In females, there was blunted responding with decreases in acquisition intake (Fig. 1C) and a main effect of decreased breakpoint on PR (Fig. 1D) .
Next we examined the extinction and reinstatement data following the 0.75 mg/kg dose (Fig. 2) . While there was no difference between Sal-and Mor-F1 males at this dose during extinction, there was a significant attenuation of priming induced reinstatement ( Fig. 2A and B) . In contrast, female Mor-F1 animals, similar to their responding during acquisition and PR, demonstrated decreased responding during extinction and reinstatement ( Fig. 2C  and D ). There were no differences in extinction or reinstatement between Sal-and Mor-F1 animals at either of the other two doses (Fig. S1 ). The effects observed during morphine self-administration behavior in the F1 animals were not due to a general operant learning deficit as there were no differences in acquisition, PR, extinction, or reinstatement when sucrose pellets were used as the reinforcer in place of morphine (Fig. S2) .
F2 morphine self-administration acquisition, progressive ratio, extinction, reinstatement
Based on the results from the F1 generation, we chose to test F2 animals using the middle (0.75 mg/kg/infusion) dose. F2 animals (maternal line) were tested during adulthood using the same selfadministration paradigm and dose as that used for F1 animals. The pattern of behavior observed in the male F1 animals was also observed in the male F2 animals. Thus, there were no differences in self-administration acquisition, PR, or extinction between Sal-F2 and Mor-F2 males. However, Mor-F2 males had significantly attenuated morphine-primed reinstatement when compared with Sal-F2 males (Fig. 3AeD) . In females, the blunted responding during acquisition was maintained in the F2 animals while no other differences were observed (Fig. 3EeH) .
Gene expression changes in the nucleus accumbens of F1 and F2 animals
Gene expression in the nucleus accumbens of male and female F1 adults was analyzed using RNA sequencing. Using expression change analysis of PacBio sequencing data, genes differentially expressed between Mor-F1 and Sal-F1 groups were identified (Fig. 4A) . RNA-sequencing results were interrogated using gene ontology analysis (PANTHER). This highlighted differences in a set of genes related to synaptic function and plasticity, which were identified for follow up qPCR analysis. These included AMPA glutamate receptor type 2 (Gria2), synaptosomal-associated protein of 25 kDa (Snap25) and ZW10 interacting kinetochore protein (Zwint), which is involved in kinetochore function and interacts directly with Snap25. Myelin basic protein (Mbp), a developmental gene critical for myelination, was also measured.
qPCR analysis of target genes
In F1 animals, there were no significant differences in Gria2 or Snap25 as a function of maternal morphine history in either sex, but there was a significant decrease in the expression of Zwint in the Mor-F1 females (Fig. 4L) . In F2 animals, however, there were significant changes in all three of these genes, and these effects were sex-specific. Both Gria2 and Snap25 had lower expression in Mor-F2 females compared with Sal-F2 females, and both Snap25 and Zwint had higher levels of expression in Mor-F2 males compared with Sal-F2 males (Fig. 4) .
With regard to Mbp there was decreased expression in Mor-F1 males compared with Sal-F1 males. However, the opposite pattern was observed in F2 males. Thus, increased expression was observed in Mor-F2 males when compared with Sal-F2 males (Fig. 5) . In contrast, Mor-F1 and Mor-F2 females expressed lower levels of Mbp in the nucleus accumbens when compared to their appropriate control (Fig. 5) . Two additional genes identified via sequencing were also examined, however, no differences in either apolipoprotein E (ApoE) or thymosin beta-4, x-linked (Tmsb4x) as a function of maternal morphine history in either generation were observed (data not shown).
Discussion
The results of the present study demonstrate transgenerational effects in progeny of females exposed to morphine during adolescence. Overall, Mor-F1 animals showed decreased levels of morphine intake and attenuated relapse-like behavior, with female offspring profoundly affected across all phases. In addition, genes involved with synaptic plasticity and CNS development were dysregulated within the NAc. Some, but not all, of these effects persisted into the second generation (F2). These findings reveal that limited exposure to opioids during adolescence, even in the absence of continued use or in utero exposure, have lasting effects that persist across generations.
Mor-F1 and F2 males have blunted reinstatement behavior
In males examined at the 0.75 mg/kg dose, there were no significant differences in the rate or intake of morphine during acquisition, and no change in motivated responding during PR or extinction. However, when tested for morphine priming-induced reinstatement there was a significant decrease in drug-seeking behavior in the Mor-F1 compared to Sal-F1 males. In humans, addiction is a chronic relapsing disease characterized by compulsive drug seeking followed by periods of abstinence and relapse to drug-seeking behavior. Reinstatement is an animal model of For all panels, data is presented as mean ± SEM. For the male animals, there were no differences in extinction responding between Mor-F1 and Sal-F1, although there was a main effect of day indicating that the responding in both groups was significantly decreased at the end of extinction [F(9, 126) ¼ 28.7; P < 0.0001] (2A). However, analysis of the reinstatement data showed a main effect of dose on reinstatement behavior (2B), [F(1,28) ¼ 6.8; p < 0.05] demonstrating that both groups reinstated to a priming injection of morphine. There was also a significant interaction [F(1,28) ¼ 5.9; p < 0.05]. Sidak's post hoc analysis revealed that Mor-F1 animals responded significantly less than Sal-F1 animals following a morphine priming injection (p < 0.05). Female animals also demonstrated extinction with a significant main effect of day [F(9, 135) ¼ 49.36; p < 0.0001] but the female Mor-F1 animals also showed blunted responding compared to Sal-F1 females (2C, main effect of maternal treatment [F(1, 15) ¼ 6.7; p < 0.05]; significant interaction [F(9, 135) ¼ 3.5; p < 0.001] with Sidak's multiple comparisons test showing a decrease in responding on days 1, 2, and 3 (p < 0.05). In addition, there was also an effect on reinstatement (2D); main effect of dose [F (1,30) ¼ 13.9, p < 0.001] indicating that all animals reinstated and main effect of maternal treatment [F(1,30) ¼ 4.4, p < 0.05] indicating that Mor-F1 females had blunted responding on both reinstatement days). (n ¼ 8e9/group, see supplement for detailed n) # main effect p < 0.05, *p < 0.05 compared to Sal-F1 of same group. relapse consistently characterized in the literature as representative of a propensity towards relapse (Ahmed and Koob, 1998) . Therefore, the decreased reinstatement behavior observed in these animals could indicate a reduced susceptibility to relapse-like behavior. As there were no differences in any other aspect of selfadministration behavior at this dose, the diminished relapse-like behavior was not due to a general decrease in responding or drug intake, suggesting a selective effect on neural systems that mediate drug-primed reinstatement. Additionally, there were no changes in reinstatement behavior observed when the reinforcer was sucrose rather than morphine, indicating that these effects were not due to a general deficit in learning and/or memory. It does suggest changes in the drug memory or drug craving in these animals, resulting in decreased levels of responding during priming-induced reinstatement. Alterations that we observed in genes associated with synaptic plasticity within the NAc, a critical brain region mediating drug-primed reinstatement, support this hypothesis. Future studies are needed to determine whether these modifications in genes associated with synaptic plasticity, which were observed in non-drug exposed MOR-F1 males, mediate the observed changes in reinstatement. These data, however, provide evidence that a brief exposure to opiates during adolescence can have lasting consequences in future generations.
While examination of a higher and lower dose yielded similar patterns (i.e. decreased responding in Mor-F1 animals); 0.75 mg/ kg/infusion was the only dose that produced blunted reinstatement. Therefore, this dose was examined in the F2 generation to determine whether a similar selective effect on drug-primed reinstatement could be discerned. As with F1 males, decreased drug-primed reinstatement behavior in Mor-F2 males was also observed in the absence of any changes in acquisition, PR, or extinction. While the current study examined drug priminginduced reinstatement, future studies should examine cue or stress induced reinstatement as both modes contribute significantly to opioid relapse. Moreover, the mechanisms underlying reinstatement are divergent, and the effects observed utilizing these models may be different (Lai et al., 2013; Wang et al., 2006) which may provide more specific molecular targets.
While the mechanism of transmission to the F2 remains unclear, it does not appear to be solely due to direct effects of morphine as there was never any exposure to F2 germ cells. A number of the behavioral effects were less robust in the F2 generation compared to the F1 generation, which may implicate a role for direct exposure. In addition, exposure to opioids during the adolescent window may impact the development of both endocrine and neural circuits, which could contribute to the F1 effects to a greater extent than the F2 effect (Cicero et al., 1991; Hofford et al., 2012; Kennedy et al., 2011) . Moreover, it is not uncommon nor unexpected to see effects in only one generation, effects that skip a generation, or effects that weaken with subsequent generations (Daxinger and Whitelaw, 2012; van Otterdijk and Michels, 2016; Vassoler et al., 2014a; Yohn et al., 2015) . Additional mechanisms of transmission may include incorporation of epigenetic marks, alterations in miRNA, behavioral/ physiological changes in the F1 dam, or a combination (Rodgers et al., 2015; Vassoler and Sadri-Vakili, 2014) . Previous findings Fig. 3 . Morphine Self-Administration Acquisition, Progressive Ratio, Extinction, and Reinstatement in Male and Female F2 Animals. For all panels, data is presented as mean ± SEM. There were no differences between Mor-F2 and Sal-F2 male animals in acquisition (3A), progressive ratio (3B), or extinction (3C). There was a main effect of dose on reinstatement behavior (3D), [F(1,17) ¼ 22.2; p < 0.05] demonstrating that both groups reinstated to a priming injection of morphine. Based on the F1 data, we had the a priori hypothesis that reinstatement would be blunted and therefore conducted a post hoc analysis, which revealed that Mor-F2 animals responded significantly less than Sal-F2 animals following a morphine priming injection (p < 0.05). There was a significant decrease in total intake during acquisition (3E) for Mor-F2 females compared with Sal-F2 females [t ¼ 1.736, p < 0.05] but no differences during, progressive ratio (3F), extinction (3G), or reinstatement (3H), although both groups did reinstate to a morphine prime [main effect of dose: F(1,20) ¼ 14.68, p < 0.001]. #p < 0.05 main effect of dose, *p < 0.05 (n ¼ 12/group). using this model also documented behavioral and molecular effects in MOR-F1 males that persist into the F2 generation and implicate transgenerational modifications within the NAc . We have assessed maternal behavior using this model and showed minimal differences between Sal-F0 and Mor-F0 dams; limited to slight decreases in time spent on nest during the dark cycle (Johnson et al., 2011) . Additional pre-and/or postnatal factors may still play a role in the etiology of the observed effects. Nonetheless, overall these data support the hypothesis that additional mechanisms of inheritance, other than Mendelian genetics, play a role in modulating patterns of substance use across multiple generations.
Decreased responding for morphine in Mor-F1 and F2 females
In Mor-F1 females, there was an overall decrease in responding at all phases of the paradigm. Lower levels of morphine selfadministration on a FR1 schedule is commonly interpreted as higher drug sensitivity (Arnold and Roberts, 1997; Carroll and Lac, 1997; Doherty et al., 2009; Koob et al., 1984) . This is consistent with recent results using this same adolescent exposure regimen that showed increased place conditioning at low doses of morphine in a conditioned place preference paradigm (Vassoler et al., 2015) . However, it could also be interpreted as a decrease in motivation to obtain morphine, which is more consistent with the PR, extinction, and reinstatement data. Previously, we reported increased kappa opioid receptor gene expression in Mor-F1 and F2 males . As activity at kappa opioid receptors is thought to be largely responsible for negative effects of morphine, increased expression could result in augmented withdrawal symptoms, leading to reduced motivated responding.
Mor-F2 females also demonstrated blunted intake during the acquisition phase, although this effect did not extend to PR, extinction, or reinstatement. This change in phenotype may indicate that the initial response to morphine in Mor-F2 females is altered. The changes in gene expression related to synaptic plasticity (particularly in the F2 animals) support this notion. However, the change in phenotype from the F1 animals indicates that decreased responding observed in Mor-F1 females may partially result from direct exposure of the oocytes to morphine or to alterations in the perinatal environment in Mor-F0 dams. Additionally, in many transgenerational effects, females are less affected than males (Biglarnia et al., 2013; Timar et al., 2010; Vassoler et al., 2013) .
Recently, it was shown that offspring of cocaine experienced sires had decreased self-administration behavior (Vassoler et al., 2013) . These data are similar to those reported in the current set of studies, suggesting decreased reinforcing effectiveness of a drug in the offspring of parents exposed to the same drug prior to conception. The observed reduction in self-administration behaviors, however, should not necessarily be interpreted as a demonstration of a "protective effect" on offspring and grandoffspring with regard to addiction liability. Indeed, other data from our lab suggest additional behavioral and molecular modifications in these animals that would be expected to increase their vulnerability to addiction under various conditions (Byrnes, 2005a, b; 2008; Byrnes et al., 2011 Byrnes et al., , 2013 Johnson et al., 2011; Vassoler et al., 2014b Vassoler et al., , 2015 . Thus, what we suggest is that maternal exposure to morphine during adolescence alters the neurodevelopment of future offspring that impacts how they respond to drugs of abuse, which may be dependent upon a host of environmental and genetic factors. These genes were used to generate a heat map showing the gene expression changes in Mor-F1 animals relative to Sal-F1 animals. qPCR analysis of synaptic plasticity genes are presented as fold change relative to control (mean ± SEM). There was no change in Gria2 expression in Mor-F1 males or females (4B, 4D) or in Mor-F2 males (4C). However, there was a decrease in expression in Mor-F2 females compared with Sal-F2 females (4E). For Snap25, there was no change in either sex in the F1 generation (4F, 4H). However, in the F2 animals there was increased expression in Mor-F2 males (4G) and decreased expression in Mor-F2 females (4I). Finally, for Zwint, there were no differences in F1 males (4J) but there was an increase in Mor-F2 males (4K). There was also a decrease in Mor-F1 females (4L) but no change in Mor-F2 females (4M). *p < 0.05 detected with a two tailed student's t-test. n ¼ 8 for all groups except Mor-F1 males (n ¼ 7) and Mor-F1 females (n ¼ 7).
Dysregulation of synaptic plasticity genes
It is clear that continued drug use induces adaptive genomic changes in the central nervous system that lead to drug dependence (Koob and Kreek, 2007) . Further, epigenetic adaptations in transcriptional regulation are likely part of the observed alterations in addiction-related phenotypes in the F1 and F2 generations. Indeed, results from Pac-Bio sequencing of the NAc of F1 animals indicated changes in several genes involved in the regulation of neuronal plasticity, suggesting functional circuitry changes. Using this initial unbiased screen, we selected three genes for follow up, which showed significant differential expression and are known to regulate synaptic plasticity; Gria2, Snap25, and Zwint.
Gria2 codes for GluA2, which is implicated in the reinstatement of drug-seeking behavior for multiple drugs of abuse including cocaine and morphine (Briand et al., 2014; Dias et al., 2012; Hearing et al., 2016; LaCrosse et al., 2016; Schmidt et al., 2015) . While the sequencing results indicated that we would see changes in the F1 animals, there were no differences observed in the qPCR experiments. This discrepancy may be due to higher sensitivity of PacBio sequencing and analysis. However, when we examined the F2 animals, there was a significant decrease in Gria2 in Mor-F2 compared with Sal-F2 females. This pattern of effects observed in F2 but not F1 animals occurred throughout our analysis of gene expression changes. This may be due to compensatory changes as the behavioral differences observed in morphine self-administration were decreased in the F2 animals, or the changes may produce a deficit in a behavior paradigm that we have not yet tested. In either case, we are observing a sex-specific addiction-related molecular phenotype in F1 and F2 generations in response to opioid exposure limited to the adolescent period. Changes in AMPA receptor expression in the accumbens can affect many aspects of brain state including learning and memory, reward, and plasticity. Snap25 is involved in vesicle fusion and neurotransmitter release and thereby plays a role in synaptic plasticity. Additionally, Snap25 is down regulated in the hippocampus following morphine treatment (Xu et al., 2004) . However, similar to the effect with Gria2, Snap25 was not regulated in the F1 animals yet was altered in the F2 generation with an up regulation in Mor-F2 males and down regulation in Mor-F2 females. Zwint interacts directly with Snap25 and also plays a role in synaptic plasticity. Zwint is a relatively understudied gene but has been implicated in cancer (Endo et al., 2012; Miller, 2010) . There was no change in Zwint in the F1 males, but a down regulation in the Mor-F1 females, animals that were mated to produce F2 animals. In this next generation, an increase in the level of Zwint was observed in Mor-F2 males while expression had normalized in F2 females. Dysregulation of genes associated with synaptic plasticity may partly underlie impaired drug memory or drug seeking behavior observed in the F1 and F2 animals. Importantly, the observed changes were all measured at baseline and multiple exposures to opiates may alter how these genes are regulated .
Mbp is dysregulated in both F1 and F2 animals
Recently, myelin has come into focus because of its potential role in psychiatric diseases, including addiction (Bora et al., 2012) . Indeed, myelin and oligodendrocytes that produce myelin are proving to be important regulators in development as well as neuroplasticity, remodeling, and addiction (Bruce et al., 2010) . Additionally, oligodendrocytes express opiate receptors and produce endogenous opioids in a developmentally specific manner (Knapp et al., 1998 (Knapp et al., , 2001 , which would allow for exogenous opioids to have pronounced effects. Indeed, changes in Mbp have been shown following drug exposure in both rodents and humans with single nucleotide polymorphisms (Snp) in the Mbp gene associated with cocaine, heroin and alcohol use in humans as well as alcohol exposure in rats (Levey et al., 2014; Levran et al., 2015) . In addition, prenatal and perinatal exposures to nicotine or opiates have caused alterations in expression of Mbp in both male and female rodent progeny (Cao et al., 2013; Sanchez et al., 2008) . Moreover, in humans white matter changes have been observed in children prenatally exposed to opiates (Walhovd et al., 2010) . Finally, prolonged self-administration of cocaine causes a down regulation in MBP protein expression in the precommisural striatum in both non-human primates as well as in humans (Bannon et al., 2005; Smith et al., 2014) . Here, we report that exposure to opiates during adolescence has effects on Mbp which persist for multiple generations. We found down regulation of Mbp in both Mor-F1 males and females. This effect extended to F2 females and reversed in the F2 males. Mbp is particularly well situated to play a significant role in the transmission of opiate related neurodevelopmental changes. It is regulated by opioids, has developmentally mediated expression patterns, and has been linked with addiction in multiple animal models as well as in humans (Cao et al., 2013; Levey et al., 2014; Levran et al., 2015; Sanchez et al., 2008) .
Conclusions
These data are the first to demonstrate transgenerational epigenetic effects on motivated responding for drugs of abuse. The majority of previous studies on transgenerational effects of drugs of abuse have only documented effects in the F1 generation. Moreover, the molecular changes clearly indicate the persistence of epigenetic modifications across two generations. Perhaps even more intriguing, they suggest the emergence of novel molecular effects in the F2 generation which cannot be predicted based on F1 effects.
While these results may appear contradictory from data . Expression of myelin basic protein in the nucleus accumbens of male and female F1 and F2 animals. Data are presented as fold change relative to control (mean ± SEM). In both Mor-F1 males and females there was a down regulation of Mbp relative to the respective Sal-F1 control (5A, 5C). In the F2 generation, the Mor-F2 females continued to show this down regulation of Mbp (5D) while Mor-F2 males showed an increase in expression levels (5B). *p < 0.05 detected with a two-tailed student's t-test. n ¼ 8 for all groups except Mor-F1 males (n ¼ 7) and Mor-F1 females (n ¼ 7).
suggesting increased risk of drug addiction in the children of substance abusers (Levran et al., 2012) , to date there have been no studies in human populations that examine the generational effect of discreet adolescent exposure to opioids. Moreover, studies of this nature would be unfeasible due to the numerous genetic and environmental factors that contribute to abuse liability in people.
From an evolutionary perspective, these effects may represent an epigenetic mechanism preparing progeny for an environment in which increased opioid receptor activation is possible. Indeed, this would not be the first example of a hypothetical "protective" effect as a consequence of parental drug exposure (Vassoler et al., 2013) . However, under certain conditions this "protective" effect may be detrimental. For example, the observed changes may be indicative of a blunted reward system or a depressive-like phenotype, both of which are known to increase the risk of addictive behaviors in humans. Regardless of the direction of the effect, what these data represent is that maternal adolescent exposure to opioids in the absence of in utero exposure has lasting effects on addictive-like behaviors in offspring and grandoffspring. In human populations, the interaction between these epigenetic developmental changes, genetics, and environment may mitigate or exacerbate addictive behaviors in offspring and may provide a mechanism underlying variability in human phenotypes.
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